From sciencedirect.com (https://www.sciencedirect.com/science/article/pii/S2452318621000350?via%3Dihub), RCobos-Campos, AApiñaniz, NParraza, JCordero, SGarcía, and EOrruñ, “Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection”:
Abstract
Purpose of the study
Currently no treatment has been proven to be efficacious for patients with early symptoms of COVID-19. Although most patients present mild or moderate symptoms, up to 5-10% may have a poor disease progression, so there is an urgent need for effective drugs, which can be administered even before the onset of severe symptoms, i.e. when the course of the disease is modifiable. Recently, promising results of several studies on oral ivermectin have been published, which has prompted us to conduct the present review of the scientific literature.
Methods
A narrative review has been carried out, focusing on the following four main topics: a) short-term efficacy in the treatment of the disease…